These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31887619)

  • 1. Transfer RNA methyltransferase gene NSUN2 mRNA expression modifies the effect of T cell activation score on patient survival in head and neck squamous carcinoma.
    Lu L; Gaffney SG; Cannataro VL; Townsend J
    Oral Oncol; 2020 Feb; 101():104554. PubMed ID: 31887619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High tRNA Transferase NSUN2 Gene Expression is Associated with Poor Prognosis in Head and Neck Squamous Carcinoma.
    Lu L; Zhu G; Zeng H; Xu Q; Holzmann K
    Cancer Invest; 2018 Apr; 36(4):246-253. PubMed ID: 29775108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C Virus RNA Transcript Associates with Prognosis in Non-human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma.
    Tang B; Zhu G; Chen C; Zheng S; Pu Y; Xu Y; Huang H; Wang G; Huang D; Liu Y; Zhang X
    Laryngoscope; 2021 Aug; 131(8):1774-1781. PubMed ID: 33592124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 mRNA expression modifies the effect of T cell activation score on patient survival in breast cancer.
    Lu L; Huang H; Zhou J; Ma W; Mackay S; Wang Z
    BMC Cancer; 2019 Apr; 19(1):387. PubMed ID: 31023256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study.
    Zhang L; Li B; Peng Y; Wu F; Li Q; Lin Z; Xie S; Xiao L; Lin X; Ou Z; Cai T; Rong H; Fan S; Li J
    Oral Oncol; 2020 Nov; 110():104943. PubMed ID: 32919362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
    Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
    APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma.
    Yang C; Mei H; Peng L; Jiang F; Xie B; Li J
    Comput Math Methods Med; 2020; 2020():7397132. PubMed ID: 33456497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of notch signaling on the prognosis of patients with head and neck squamous cell carcinoma.
    Grilli G; Hermida-Prado F; Álvarez-Fernández M; Allonca E; Álvarez-González M; Astudillo A; Moreno-Bueno G; Cano A; García-Pedrero JM; Rodrigo JP
    Oral Oncol; 2020 Nov; 110():105003. PubMed ID: 32932170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA methyltransferase NSUN2 promotes hypopharyngeal squamous cell carcinoma proliferation and migration by enhancing TEAD1 expression in an m
    Chen L; Ding J; Wang B; Chen X; Ying X; Yu Z; Dong P
    Exp Cell Res; 2021 Jul; 404(2):112664. PubMed ID: 34048786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
    Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 12. DNA methylation-mediated Klotho silencing is an independent prognostic biomarker of head and neck squamous carcinoma.
    Zhu Y; Cao X; Zhang X; Chen Q; Wen L; Wang P
    Cancer Manag Res; 2019; 11():1383-1390. PubMed ID: 30863149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
    Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
    Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel seven‑miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients.
    Lu L; Wu Y; Feng M; Xue X; Fan Y
    Mol Med Rep; 2019 Nov; 20(5):4340-4348. PubMed ID: 31545440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas.
    Succaria F; Kvistborg P; Stein JE; Engle EL; McMiller TL; Rooper LM; Thompson E; Berger AE; van den Brekel M; Zuur CL; Haanen J; Topalian SL; Taube JM
    Cancer Immunol Immunother; 2021 May; 70(5):1227-1237. PubMed ID: 33125511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
    Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
    Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of the expression and prognosis for CDCAs in head and neck squamous cell carcinoma.
    Wu ZH; Fang M; Zhou Y
    PLoS One; 2020; 15(7):e0236678. PubMed ID: 32716971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of the association between MHC class I downregulation and PD-L1 upregulation in head and neck squamous cell carcinoma patients.
    Yoo SH; Keam B; Ock CY; Kim S; Han B; Kim JW; Lee KW; Jeon YK; Jung KC; Chung EJ; Kwon SK; Ahn SH; Sung MW; Heo DS
    Sci Rep; 2019 May; 9(1):7680. PubMed ID: 31118488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active HPV infection and its influence on survival in head and neck squamous-cell cancer.
    Janecka-Widła A; Mucha-Małecka A; Majchrzyk K; Halaszka K; Przewoźnik M; Słonina D; Biesaga B
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1677-1692. PubMed ID: 32372145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.